Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Smoking Behaviors in Arab Americans: Acculturation and Health Beliefs.

Ghadban R, Haddad L, Thacker LR 2nd, An K, Balster RL, Salyer J.

J Transcult Nurs. 2019 Mar;30(2):115-123. doi: 10.1177/1043659618783235. Epub 2018 Jun 29.

PMID:
29957137
2.

Ensure global access to naloxone for opioid overdose management.

Balster RL, Walsh SL.

Addiction. 2016 Apr;111(4):589-90. doi: 10.1111/add.13274. No abstract available.

PMID:
26995171
3.

William L Woolverton.

Balster RL.

Neuropsychopharmacology. 2014 Dec;39(13):3136. doi: 10.1038/npp.2014.255. No abstract available.

4.

Interview with Eddy Award Winner Dr Robert Balster.

Balster RL.

Drug Alcohol Depend. 2014 Oct 1;143:283-4. No abstract available.

PMID:
25343166
5.
6.

Evidence acquisition and evaluation for evidence summit on enhancing provision and use of maternal health services through financial incentives.

Higgs ES, Stammer E, Roth R, Balster RL.

J Health Popul Nutr. 2013 Dec;31(4 Suppl 2):23-35. Review.

PMID:
24992801
7.

Financial incentives and maternal health: where do we go from here?

Morgan L, Stanton ME, Higgs ES, Balster RL, Bellows BW, Brandes N, Comfort AB, Eichler R, Glassman A, Hatt LE, Conlon CM, Koblinsky M.

J Health Popul Nutr. 2013 Dec;31(4 Suppl 2):8-22. Review.

PMID:
24992800
8.

William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants.

Nader MA, Balster RL, Henningfield JE.

Neuropharmacology. 2014 Dec;87:4-8. doi: 10.1016/j.neuropharm.2014.05.004. Epub 2014 May 20. Review.

9.

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.

O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP.

Pain. 2013 Nov;154(11):2324-34. doi: 10.1016/j.pain.2013.06.035. Review.

PMID:
24148704
10.

Obituary: William L. Woolverton.

Balster RL, Nader MA, Freeman KB.

Psychopharmacology (Berl). 2013 Sep;229(2):379-81. doi: 10.1007/s00213-013-3233-3. Epub 2013 Aug 16. No abstract available.

PMID:
23949257
11.

GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR.

Neuropsychopharmacology. 2013 Apr;38(5):729-42. doi: 10.1038/npp.2012.246. Epub 2012 Dec 5.

12.

Coordinated and evidence-based policy and practice for protecting children outside of family care.

Boothby N, Balster RL, Goldman P, Wessells MG, Zeanah CH, Huebner G, Garbarino J.

Child Abuse Negl. 2012 Oct;36(10):743-51. doi: 10.1016/j.chiabu.2012.09.007. Epub 2012 Oct 26. Review. No abstract available.

PMID:
23107455
13.

Evidence acquisition and evaluation for a U.S. Government Evidence Summit on Protecting Children Outside Family Care.

Higgs ES, Zlidar VM, Balster RL.

Child Abuse Negl. 2012 Oct;36(10):689-700. doi: 10.1016/j.chiabu.2012.09.002. Epub 2012 Oct 18. Review.

PMID:
23083899
14.

Hijacking of Basic Research: The Case of Synthetic Cannabinoids.

Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF.

Methods Rep RTI Press. 2011 Nov;2011. pii: 17971.

15.

Areca nut dependence among chewers in a South Indian community who do not also use tobacco.

Bhat SJ, Blank MD, Balster RL, Nichter M, Nichter M.

Addiction. 2010 Jul;105(7):1303-10. doi: 10.1111/j.1360-0443.2010.02952.x.

16.

Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report.

Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell AG, Coleman JJ, Dart RC, Gorodetzky CW, O'Keeffe C, Sellers EM, Vocci F, Walsh SL.

Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S65-71. doi: 10.1016/j.drugalcdep.2009.08.006. Epub 2009 Sep 23.

17.

Risk management and post-marketing surveillance of CNS drugs: an introduction.

Balster RL, Johanson CE, Walsh SL.

Drug Alcohol Depend. 2009 Dec 1;105 Suppl 1:S1-3. doi: 10.1016/j.drugalcdep.2009.08.001. Epub 2009 Sep 9. No abstract available.

PMID:
19744805
18.

Preclinical evaluation of the abuse potential of the analgesic bicifadine.

Nicholson KL, Balster RL, Golembiowska K, Kowalska M, Tizzano JP, Skolnick P, Basile AS.

J Pharmacol Exp Ther. 2009 Jul;330(1):236-48. doi: 10.1124/jpet.109.150540. Epub 2009 Apr 8.

19.

Classification of abused inhalants.

Balster RL, Cruz SL, Howard MO, Dell CA, Cottler LB.

Addiction. 2009 Jun;104(6):878-82. doi: 10.1111/j.1360-0443.2008.02494.x. Epub 2009 Feb 10.

PMID:
19215599
20.

The discriminative stimulus effects of N-methyl-D-aspartate glycine-site ligands in NMDA antagonist-trained rats.

Nicholson KL, Balster RL.

Psychopharmacology (Berl). 2009 Apr;203(2):441-51. doi: 10.1007/s00213-009-1469-8. Epub 2009 Jan 28.

21.

Availability and characteristics of betel products in the U.S.

Blank M, Deshpande L, Balster RL.

J Psychoactive Drugs. 2008 Sep;40(3):309-13.

22.

Drug withdrawal, cocaine and sedative use disorders increase the need for mechanical ventilation in medical patients.

de Wit M, Gennings C, Zilberberg M, Burnham EL, Moss M, Balster RL.

Addiction. 2008 Sep;103(9):1500-8. doi: 10.1111/j.1360-0443.2008.002267.x.

PMID:
18636996
23.

Effects of a universal classroom behavior program in first and second grades on young adult problem outcomes.

Kellam SG, Reid J, Balster RL.

Drug Alcohol Depend. 2008 Jun 1;95 Suppl 1:S1-4. doi: 10.1016/j.drugalcdep.2008.01.006. Epub 2008 Mar 17. No abstract available.

24.
25.

Inhalant use among incarcerated adolescents in the United States: prevalence, characteristics, and correlates of use.

Howard MO, Balster RL, Cottler LB, Wu LT, Vaughn MG.

Drug Alcohol Depend. 2008 Mar 1;93(3):197-209. Epub 2007 Nov 5.

PMID:
17983710
26.

Characterizing early cigarette use episodes in novice smokers.

Acosta MC, Eissenberg T, Nichter M, Nichter M, Balster RL; Tobacco Etiology Research Network (TERN).

Addict Behav. 2008 Jan;33(1):106-21. Epub 2007 Sep 8.

PMID:
17913378
27.

Addiction epidemiology in adolescents receiving inpatient psychiatric treatment.

Weaver MF, Dupre MA, Cropsey KL, Koch JR, Sood BA, Wiley JL, Balster RL.

Addict Behav. 2007 Dec;32(12):3107-13. Epub 2007 Jun 9.

28.

An exploratory study of drug abuse and dependence information in package inserts.

Phipps LB, Balster RL, Slattum PW, Kirkwood CK.

J Addict Dis. 2007;26(2):25-34.

PMID:
17594995
29.

Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.

O'Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE, Markou A, Zorrilla EP, Koob GF.

J Pharmacol Exp Ther. 2007 Jan;320(1):180-93. Epub 2006 Oct 18.

PMID:
17050784
30.

Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report.

Grudzinskas C, Balster RL, Gorodetzky CW, Griffiths RR, Henningfield JE, Johanson CE, Mansbach RS, McCormick CG, Schnoll SH, Strain EC, Wright C.

Drug Alcohol Depend. 2006 Jun;83 Suppl 1:S77-82. Epub 2006 Mar 31.

PMID:
16580154
31.
32.

Expanding the role for scientists from low and middle income countries in the journal publication process.

Balster RL.

Drug Alcohol Depend. 2006 May 20;82(3):185-6. Epub 2006 Feb 17. No abstract available.

PMID:
16483728
33.

Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats.

Vann RE, Balster RL, Beardsley PM.

Psychopharmacology (Berl). 2006 Mar;184(3-4):482-93. Epub 2005 Jul 7. Erratum in: Psychopharmacology (Berl). 2006 Mar;184(3-4):652.

PMID:
16001123
34.

Ian Stolerman service as editor for Drug and Alcohol Dependence.

Balster RL.

Drug Alcohol Depend. 2005 May 9;78(2):111-2. No abstract available.

PMID:
15845313
35.

Effects of abused inhalants and GABA-positive modulators in dizocilpine discriminating inbred mice.

Shelton KL, Balster RL.

Pharmacol Biochem Behav. 2004 Oct;79(2):219-28.

PMID:
15501297
36.

Using growth models to relate acquisition of nicotine self-administration to break point and nicotinic receptor binding.

Donny EC, Lanza ST, Balster RL, Collins LM, Caggiula A, Rowell PP.

Drug Alcohol Depend. 2004 Jul 15;75(1):23-35.

PMID:
15225886
37.

Analyzing the acquisition of drug self-administration using growth curve models.

Lanza ST, Donny EC, Collins LM, Balster RL.

Drug Alcohol Depend. 2004 Jul 15;75(1):11-21.

PMID:
15225885
38.
39.

Intravenous self-administration of abused solvents and anesthetics in mice.

Blokhina EA, Dravolina OA, Bespalov AY, Balster RL, Zvartau EE.

Eur J Pharmacol. 2004 Feb 6;485(1-3):211-8.

PMID:
14757143
40.

Toluene inhalation produces a conditioned place preference in rats.

Gerasimov MR, Collier L, Ferrieri A, Alexoff D, Lee D, Gifford AN, Balster RL.

Eur J Pharmacol. 2003 Sep 5;477(1):45-52.

PMID:
14512097
41.

Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats.

Nicholson KL, Balster RL.

Psychopharmacology (Berl). 2003 Nov;170(2):215-24. Epub 2003 Jul 8.

PMID:
12851738
42.

Guidelines and methodological reviews concerning drug abuse liability assessment.

Balster RL, Bigelow GE.

Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S13-40. Review.

PMID:
12759195
43.

Evaluation of toluene dependence and cross-sensitization to diazepam.

Wiley JL, Bale AS, Balster RL.

Life Sci. 2003 May 16;72(26):3023-33.

PMID:
12706489
44.

Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.

Kozikowski AP, Johnson KM, Deschaux O, Bandyopadhyay BC, Araldi GL, Carmona G, Munzar P, Smith MP, Balster RL, Beardsley PM, Tella SR.

J Pharmacol Exp Ther. 2003 Apr;305(1):143-50.

PMID:
12649362
45.

Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-D-aspartic acid in mice.

Cruz SL, Gauthereau MY, Camacho-Muñoz C, López-Rubalcava C, Balster RL.

Behav Brain Res. 2003 Mar 18;140(1-2):195-202.

PMID:
12644292
46.

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

Wiley JL, Harvey SA, Balster RL, Nicholson KL.

Psychopharmacology (Berl). 2003 Feb;165(4):378-85. Epub 2002 Nov 30.

PMID:
12459931
47.

The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects.

Beardsley PM, Ratti E, Balster RL, Willetts J, Trist D.

Behav Pharmacol. 2002 Nov;13(7):583-92.

PMID:
12409996
49.

Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats.

Munzar P, Li H, Nicholson KL, Wiley JL, Balster RL.

Psychopharmacology (Berl). 2002 Mar;160(3):331-6. Epub 2002 Jan 31.

PMID:
11889503
50.

Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys.

Beardsley PM, Dance ME, Balster RL, Munzar P.

Eur J Pharmacol. 2002 Jan 25;435(2-3):209-16.

PMID:
11821028

Supplemental Content

Loading ...
Support Center